Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

BUY
$0.37 - $1.69 $92 - $422
250 Added 250.0%
350 $0
Q2 2023

Jul 11, 2023

SELL
$0.39 - $1.69 $94 - $408
-242 Reduced 70.76%
100 $0
Q1 2023

Apr 17, 2023

SELL
$1.75 - $3.14 $14 - $25
-8 Reduced 2.29%
342 $0
Q4 2022

Jan 10, 2023

SELL
$2.09 - $4.32 $505 - $1,045
-242 Reduced 40.88%
350 $0
Q3 2022

Oct 14, 2022

SELL
$2.24 - $4.18 $201 - $376
-90 Reduced 13.2%
592 $2,000
Q2 2022

Jul 11, 2022

BUY
$2.85 - $7.77 $399 - $1,087
140 Added 25.83%
682 $2,000
Q1 2022

May 26, 2022

SELL
$5.7 - $9.3 $336 - $548
-59 Reduced 9.82%
542 $4,000
Q4 2021

Jan 12, 2022

BUY
$8.73 - $15.27 $2,182 - $3,817
250 Added 71.23%
601 $5,000
Q2 2021

Jul 12, 2021

SELL
$22.12 - $32.06 $442 - $641
-20 Reduced 5.39%
351 $8,000
Q1 2021

Apr 21, 2021

BUY
$26.12 - $52.17 $5,877 - $11,738
225 Added 154.11%
371 $12,000
Q3 2020

Oct 06, 2020

SELL
$14.17 - $19.48 $13,475 - $18,525
-951 Reduced 86.69%
146 $2,000
Q2 2020

Jul 10, 2020

SELL
$13.25 - $21.72 $4,902 - $8,036
-370 Reduced 25.22%
1,097 $18,000
Q1 2020

Apr 07, 2020

BUY
$9.73 - $24.9 $4,865 - $12,450
500 Added 51.71%
1,467 $21,000
Q4 2019

Jan 15, 2020

SELL
$14.22 - $23.38 $1,663 - $2,735
-117 Reduced 10.79%
967 $20,000
Q2 2019

Jul 16, 2019

BUY
$38.73 - $52.03 $8,869 - $11,914
229 Added 26.78%
1,084 $44,000
Q1 2019

Apr 11, 2019

SELL
$28.11 - $50.77 $5,846 - $10,560
-208 Reduced 19.57%
855 $37,000
Q4 2018

Jan 18, 2019

BUY
$26.22 - $56.89 $6,292 - $13,653
240 Added 29.16%
1,063 $29,000
Q3 2018

Oct 11, 2018

SELL
$24.31 - $52.74 $2,941 - $6,381
-121 Reduced 12.82%
823 $40,000
Q2 2018

Aug 09, 2018

BUY
$20.25 - $35.96 $19,116 - $33,946
944 New
944 $28,000

Others Institutions Holding CGC

About Canopy Growth Corp


  • Ticker CGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 480,284,000
  • Market Cap $2.2B
  • Description
  • Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include d...
More about CGC
Track This Portfolio

Track Gradient Investments LLC Portfolio

Follow Gradient Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gradient Investments LLC with notifications on news.